Merck | MRK - Sales Revenues

Stock Price
128.30
Daily Change
2.65 2.11%
Monthly
0.98%
Yearly
-5.70%
Q1 Forecast
123.95

Merck reported EUR5.32B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Adidas EUR 6.63B 680M Sep/2025
Adyen EUR 1.09B 558.7M Jun/2025
Akzo Nobel EUR 2.37B 180M Dec/2025
Alcon AG USD 2.7B 110M Dec/2025
Amadeus IT EUR 1.64B 10M Sep/2025
Amarin USD 49.67M 23.07M Sep/2025
AstraZeneca USD 15.5B 313M Dec/2025
BASF EUR 14.03B 298M Dec/2025
Bayer EUR 9.66B 1.08B Sep/2025
Beiersdorf EUR 2.35B 150M Sep/2025
Covestro EUR 3.17B 210M Sep/2025
Danone EUR 6.68B 200M Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Galapagos EUR 900.82M 835.52M Dec/2025
Genmab DKK 5.86B 580M Jun/2025
Givaudan CHF 1.87B 1.51B Jun/2024
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.87B 20M Sep/2025
Henkel EUR 5.16B 5.61B Jun/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Infineon EUR 3.66B 280M Dec/2025
Linde USD 8.62B 120M Sep/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.32B 890M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Philips EUR 5.1B 797M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
UCB EUR 3.49B 129M Jun/2025